Cite
HARVARD Citation
Garg, A. et al. (2020). Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study. Pediatric blood & cancer. 67 (9), p. n/a. [Online].